期刊
CARCINOGENESIS
卷 35, 期 9, 页码 2068-2073出版社
OXFORD UNIV PRESS
DOI: 10.1093/carcin/bgu107
关键词
-
类别
资金
- National Human Genome Research Institute (NHGRI) [U01HG004803, U01HG004798, U01HG004802, U01HG004790, U01HG0s04801]
- NHGRI PAGE program [U01HG004798, U01HG004802, U01HG004790]
- NHGRI PAGE program (NHGRI ARRA supplement)
- Vanderbilt CTSA grant from NCATS/NIH [UL1 TR000445]
- National Cancer Institute [R37CA54281, R01 CA082838]
- National Heart, Lung and Blood Institute
- NIH
- U.S. Department of Health and Human Services [N01WH22110, 24152, 321002, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]
- National Cancer Institute (NCI) [R01 CA082838, R01 CA91019, R01 CA77398]
- Fred Hutchinson Cancer Research Center
- National Institutes of Health [R01 CA134958, R01CA082838, P01 CA87969, R01 CA49449]
- Intramural Research Program of the NCI
- NCI
- [R35 CA39779]
- [R01 CA75977]
- [R03 CA80636]
- [N01 HD 2 3166]
- [K05 CA 92002]
- [R01 CA 105212]
- [R01 CA87538]
- EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD023166] Funding Source: NIH RePORTER
- NATIONAL CANCER INSTITUTE [R01CA098346, R01CA049449, P01CA087969, R01CA082838, R37CA054281, R01CA087538, K05CA092002, P30CA071789, P30CA016359, R01CA105212, R03CA080636, ZIACP010126, R35CA039779, R01CA075977, R01CA077398, R01CA134958, R01CA091019] Funding Source: NIH RePORTER
- NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER
- NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004790, U01HG004801, U01HG004802, U01HG004798, U01HG004803, U01HG007376] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER
- WOMEN&apos
- S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH042119, N01WH032115, N01WH032100, N01WH032101, N01WH032109, N01WH042107, N01WH042124, N01WH042116, N01WH042118, N01WH032108, N01WH042114, N01WH042130, N01WH042122, N01WH042123, N01WH042121, N01WH032111, N01WH042108, N01WH032118, N01WH042132, N01WH042111, N01WH042120, N01WH032113, N01WH042115, N01WH032122, N01WH042117, N01WH042110, N01WH032112, N01WH042126, N01WH032119, N01WH042131, N01WH042112, N01WH042125, N01WH042113, N01WH032106, N01WH042129, N01WH032105, N01WH042109, N01WH032102, N01WH022110] Funding Source: NIH RePORTER
Genome-wide association studies (GWAS) have identified a large number of cancer-associated single nucleotide polymorphisms (SNPs), several of which have been associated with multiple cancer sites suggesting pleiotropic effects and shared biological mechanisms across some cancers. We hypothesized that SNPs associated with other cancers may be additionally associated with endometrial cancer. We examined 213 SNPs previously associated with 14 other cancers for their associations with endometrial cancer in 3758 endometrial cancer cases and 5966 controls of European ancestry from two consortia: Population Architecture Using Genomics and Epidemiology and the Epidemiology of Endometrial Cancer Consortium. Study-specific logistic regression estimates adjusted for age, body mass index and the most significant principal components of genetic ancestry were combined using fixed-effect meta-analysis to evaluate the association between each SNP and endometrial cancer risk. A Bonferroni-corrected P value of 2.35 x 10(-4) was used to determine statistical significance of the associations. SNP rs7679673, similar to 6.3 kb upstream of TET2 and previously reported to be associated with prostate cancer risk, was associated with endometrial cancer risk in the direction opposite to that for prostate cancer [meta-analysis odds ratio = 0.87 (per copy of the C allele), 95% confidence interval = 0.81, 0.93; P = 7.37 x 10(-5)] with no evidence of heterogeneity across studies (P heterogeneity = 0.66). This pleiotropic analysis is the first to suggest TET2 as a susceptibility locus for endometrial cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据